A Primer on Common Supplements and Dietary Measures Used by Patients with Inflammatory Bowel Disease

Overview

Journal Ther Adv Chronic Dis

Publisher Sage Publications

Date 2023 Jul 10

PMID 37426698

Authors

Hadi J Minhas

Konstantinos Papamichael

Adam S Cheifetz

Robert J Gianotti

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is a chronic disease of the intestines. The pathophysiology of IBD, namely Crohn's disease and ulcerative colitis, is a complex interplay between environmental, genetic, and immune factors. Physicians and patients often seek complementary and alternative medicines (CAMs) as primary and supplementary treatment modalities. CAMs in IBD span a wide range of plants, herbs, pre/probiotics, and include formulations, such as cannabis, curcumin, fish oil, and De Simone Formulation. Dietary measures are also used to improve symptoms by attempting to target trigger foods and reducing inflammation. Examples include the specific carbohydrate diet, the Mediterranean diet, and a diet low in fermentable oligo-, di- and monosaccharides as well as polyols (FODMAP). We examine and review the most common complementary supplements and diets used by patients with IBD.

Citing Articles

Key Focus Areas in Pouchitis Therapeutic Status: A Narrative Review.

Hosseini-Asl S, Mehrabani G, Masoumi S Iran J Med Sci. 2024; 49(8):472-486.

PMID: 39205822 PMC: 11347594. DOI: 10.30476/ijms.2024.100782.3326.

Potential Diagnostic Role of Hepcidin in Anemic Patients Affected by Inflammatory Bowel Disease: A Systematic Review.

Ferrari F, Carini M, Zanella I, Treglia G, Luglio G, Bresciani R Diagnostics (Basel). 2024; 14(4).

PMID: 38396414 PMC: 10887700. DOI: 10.3390/diagnostics14040375.

References

Yanai H, Levine A, Hirsch A, Sigall Boneh R, Kopylov U, Eran H . The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol. 2021; 7(1):49-59. DOI: 10.1016/S2468-1253(21)00299-5. View

Sandborn W, Targan S, Byers V, Rutty D, Mu H, Zhang X . Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol. 2012; 108(1):90-8. PMC: 3538174. DOI: 10.1038/ajg.2012.340. View

Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N . Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. J Gastroenterol. 2019; 55(2):169-180. DOI: 10.1007/s00535-019-01625-2. View

Grammatikopoulou M, Goulis D, Gkiouras K, Nigdelis M, Papageorgiou S, Papamitsou T . Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials. Nutrients. 2020; 12(12). PMC: 7760970. DOI: 10.3390/nu12123648. View

Park M, Kwon H, Sung M . Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011; 88(11-12):486-92. DOI: 10.1016/j.lfs.2011.01.010. View

Lin S, Cheifetz A . The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018; 14(7):415-425. PMC: 6111500. View

Feagan B, Sandborn W, Mittmann U, Bar-Meir S, DHaens G, Bradette M . Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA. 2008; 299(14):1690-7. DOI: 10.1001/jama.299.14.1690. View

Irving P, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N . A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis. Inflamm Bowel Dis. 2018; 24(4):714-724. DOI: 10.1093/ibd/izy002. View

Yanai H, Salomon N, Lahat A . Complementary Therapies in Inflammatory Bowel Diseases. Curr Gastroenterol Rep. 2016; 18(12):62. DOI: 10.1007/s11894-016-0537-6. View

10.

Tasneem S, Liu B, Li B, Choudhary M, Wang W . Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacol Res. 2018; 139:126-140. DOI: 10.1016/j.phrs.2018.11.001. View

11.

Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E . Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002; 37(4):444-9. DOI: 10.1080/003655202317316088. View

12.

Seidner D, Lashner B, Brzezinski A, Banks P, Goldblum J, Fiocchi C . An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005; 3(4):358-69. DOI: 10.1016/s1542-3565(04)00672-x. View

13.

Cohen S, Gold B, Oliva S, Lewis J, Stallworth A, Koch B . Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2014; 59(4):516-21. DOI: 10.1097/MPG.0000000000000449. View

14.

Altobelli E, Del Negro V, Angeletti P, Latella G . Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017; 9(9). PMC: 5622700. DOI: 10.3390/nu9090940. View

15.

Middleton S, Naylor S, Woolner J, Hunter J . A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther. 2002; 16(6):1131-5. DOI: 10.1046/j.1365-2036.2002.01286.x. View

16.

Cox S, Lindsay J, Fromentin S, Stagg A, McCarthy N, Galleron N . Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2019; 158(1):176-188.e7. DOI: 10.1053/j.gastro.2019.09.024. View

17.

Lewis J, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman M . A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease. Gastroenterology. 2021; 161(3):837-852.e9. PMC: 8396394. DOI: 10.1053/j.gastro.2021.05.047. View

18.

Sadeghi N, Mansoori A, Shayesteh A, Hashemi S . The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res. 2019; 34(5):1123-1133. DOI: 10.1002/ptr.6581. View

19.

Fedorak R, Feagan B, Hotte N, Leddin D, Dieleman L, Petrunia D . The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. Clin Gastroenterol Hepatol. 2014; 13(5):928-35.e2. DOI: 10.1016/j.cgh.2014.10.031. View

20.

Marconi A, Di Forti M, Lewis C, Murray R, Vassos E . Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophr Bull. 2016; 42(5):1262-9. PMC: 4988731. DOI: 10.1093/schbul/sbw003. View